Quantifying patient preferences for bacillus Calmette-Guérin (BCG) and PD-(L)1 inhibitors in high-risk non-muscle invasive bladder cancer (NMIBC): A discrete choice experiment.

Authors: Pam Hallworth, Anthony Eccleston, Brad Mason, Brett Hauber, Bethany Bell, Josh Coulter, Lisa Marin, Allison Thompson, Joe Jones, Jane Chang, Lara Ayala-Nunes, Julia Brinkmann, Carys Guest, Adam Gater, Abin Koshy, Joseph C Cappelleri, Stephanie Chisolm, Raj Satkunasivam

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.4579

Source: Full article


Abstract

4579